Intracranial aspergillosis is a rare pathologic condition, difficult to treat and often fatal, which generally affects irnmunodepressed patients. A case of brain abscess secondary to pulmonary localization in a patient with a non-Hodgkin lymphoma is described. The most significant clinico-pathological findings of intracranial aspergillosis are examined in the light of the relevant literature.
Introduction
Aspergillosis is one of the most common mycotic infections of the brain, although CNS localization is rare. The clinical picture of CNS aspergillosis may express with different conditions: meningitis, meningoencephalitis, granuloma, brain abscess, vasculitis [11, 14, 17] .
We report an instance of a 64-year-old man affected by a non-Hodgkin lymphoma, who developed a left fronto-parietal brain abscess secondary to a pulmonary infectious focus. The various clinical and pathological features of this rare disease are also analyzed in the light of the available literature.
Case report
This patient came to our attention in July 1990 for speech and gait disturbances. Neurologic examination at admittance revealed a right hemiparesis and dysphasia. From November 1988 to December 1989 he had undergone chemotherapy (F-MACHOP protocol) following the diagnosis of non-Hodgkin Iymphoma. Eight weeks after the interruption of treatment he suffered a rapid spread of a pulmonary inflammatory condition and was, therefore, admitted to the Division of Hematology of our University. Several sputum cultures disclosed the presence of Aspergillus fumigatus, confirmed by serologic tests for Aspergillus antibodies. Chest plain X-ray and CT showed two globular lesions: one, 4 cm. in diameter was located in the superior field of the left lung and the other (2 cm. in diameter) in the median field of the right lung. The patient was consequently treated with 5-fluorocytosine (6 grams daily in divided doses). During this treatment he suddendly developed the above-mentioned neurologic symptoms. ACT of the brain was obtained which showed a left fronto-parietal hypodense lesion with an enhancing ring, 4 cm. in diameter, interpreted as a "metastatic" abscess ( Figure 1) . Therefore, the patient was transferred to our Institute and then operated on. A left parasagittal frontal craniotomy was performed and, after dural opening, the dome of a globular lesion appeared at the cortical surface and was punctured, drawing out necrotic fluid. An anterior cleavage plane between the capsule and the surrounding cerebral tissue was hardly identified, but finally the lesion was totally removed. The hypothesis of the Aspergillus as the causative agent of the brain abscess was confirmed by the evidence of typical large septate hyphae of Aspergillus fumigatus in the colture of abscess fluid. Postoperatively, amphotericin B (600 mg./ day) and 5-fluorocytosine (2 g./8 hours) therapy was established in the I.C.U. On 5th postoperative day an acute renal and cardiovascular failure occurred, and the patient died.
Discussion
Candida, Aspergillus, Cryptococcus and few species in the family of Mucoraceae are reported to be the organisms most frequently responsible for mycotic brain abscesses in immunocompromised patients [9, 11, 13, 16, 18, 20, 28, 29] . Aspergillus infection is rare and usually fatal. Only few of the 350 classified types of aspergillus show pathogenicity in humans: A. fumigatus, A. flavus, A. amstelodami, A. sjdowi, A. candidus are those more often involved in CNS infection [2, 19].
Brain aspergillosis is more fi-equently sustained by A. fumigatus [15, 34] . The treatment with antibiotics, immunosuppressors, or steroids in patients with debilitating illnesses greatly enhances the chances of Aspergillus infection as will any process of weakening of immune system [6, 8, 19, 21, 25] . Typically these patients are immunodefective and have leukemia, lymphoma, long standing diabetes, or renal diseases. The lung is most frequently affected, followed by the gastrointestinal tract and the brain [17] . Primitive brain aspergillosis is nevertheless very rare [7, 11, 21] , and commonly the infection is secondary to lung diffusion [19, 20] 
Cerebral aspergillosis needs to be treated with both chemotherapy and surgery. The drugs of choice are free amphotericin B and liposomal amphotericin. 5-fluorocytosine, fluconazole, miconazole, ketoconazole, itraconazole are also used, but their effectiveness is questioned. A synergic action against aspergillus infection is reported for amphotericin B and 5-fluor0cytosine [23] . However, the best results are achieved combining surgery and chemotherapy [15] . 
